Ulster University

• Christopher Gill

  Principal Investigator

• Vivien Coates

  Lead investigator

• Nigel Irwin

  Lead investigator

• Liam McDaid

  Principal Investigator

• Ms Alisha Coll

  Lead applicant

• Helene McNulty

  Principal Investigator

• Mr Graeme Alexander Duncan

  Lead applicant

• Charlotte Moffett

  Lead investigator

Sources: gtr.ukri.org, openalex.org, grantnav.threesixtygiving.org

• Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity

  Collaborator, Recruiting, 68 people, May 8, 2026

• NCT07096908

  Collaborator, Phase 4, Recruiting, 60 people, Jul 31, 2025

• NCT02278172

  Phase 4, Completed, 44 people, Oct 29, 2014

Sources: clinicaltrials.gov

• UKRI | Medical Research Council

  Partnership and Contribution, MAEVE: Microbiota mediated flavonoid metabolites for cognitive health, MC_PC_24020, £175K, 2024–2028, Oct 1, 2024

• Diabetes UK

  Project Grant, Identifying the unique experiences of perimenopause and menopause amongst women with Type 1 or Type 2 diabetes to inform future practice, 23/0006554, £126K, 2024–2026, May 1, 2024

• UK Research and Innovation

  EU-Funded, CITY BASED INTERVENTIONS TO STIMULATE ACTIVE MOVEMENT FOR HEALTH (CITY-MOVE), 10109214, £539K, 2024–2027, Jan 1, 2024

• Diabetes UK

  Project Grant, Resting beta-cells to reduce their metabolic demand and improve enduring glycaemic control, 22/0006448, £285K, 2023–2026, Mar 1, 2023

• UK Research and Innovation

  EU-Funded, Understanding lung cancer related risk factors and their Impact, 10063019, £470K, 2023–2026, Jan 1, 2023

• National Institute for Health Research

  Public Health Research, Effectiveness and cost-effectiveness of a peer-led walking programme to increase physical activity in inactive older adults: “Walk With Me Study”, NIHR131550, £1.1M, 2022–2025, Mar 1, 2022

• UKRI | Medical Research Council

  Partnership and Contribution, Treating Primary Aldosteronism-induced Hypertension via Microwave Ablation, MC_PC_20021, £175K, 2021–2025, Apr 1, 2021

• National Institute for Health Research

  Artificial Intelligence for Multiple Long-Term Conditions, Northern Ireland Multimorbidity Research and Discovery (NIMRAD) Consortium, NIHR202655, £109K, 2021, Feb 9, 2021

• Wellcome Trust

  Vacation Scholarships, Developing in silico tools to analyse dyslipidemia and cardiovascular disease, 216963/Z/19/Z, 2019, May 13, 2019

• Biotechnology and Biological Sciences Research Council

  Research Grant, HDHL EpiBrain: Epigenetic effects of B-vitamins on brain health throughout life, BB/S020330/1, £267K, 2019–2024, Mar 1, 2019

• Wellcome Trust

  Vacation Scholarships, The relationship between Statins, the NLRP3 Inflammasome, and Type 2 Diabetes control., 211426/Z/18/Z, 2018, May 31, 2018

• Diabetes UK

  Early-Career Small Grants for Basic Scientists, Lineage tracing of beta- to α- cell transformation in diabetes: significance and effect of therapeutic drugs, 16/0005511, £14.7K, 2017–2018, Jan 2, 2017

Sources: gtr.ukri.org, openalex.org, fundingawards.nihr.ac.uk, grantnav.threesixtygiving.org

• Impact of Sex on Age-Related Changes in Pancreatic Islet Morphology and Beta-Cell Plasticity in Mice

  Vice-Chancellor PhD studentship, Sep 23, 2026

• Senescence Biomarkers Independently Predict Disease-Related Mortality in Chronic Kidney Disease

  Sep 1, 2026

• Plasma carotenoids and (poly)phenols in people living with an ileostomy: associations with dietary intake

  May 12, 2026

• Adverse effect of age on pancreatic islet morphology, islet cell turnover and lineage-labelled hormone expression in mice

  Strategic research funding, Vice-Chancellor PhD studentship, Apr 16, 2026

• Multimorbidity trajectories and their sex-specific impacts on risk of mortality and re-hospitalisation

  Mar 7, 2026

• B vitamins, immune function and the ageing brain: a critical review of the evidence, mechanisms and potential role of the gut microbiome

  Feb 16, 2026

• Accelerated epigenetic age in hypertension: a systematic review and meta-analysis

  Jan 9, 2026

• Influence of Fish Consumption and ω-3 Supplementation on the ω-3 Index of Young Adults: A 2 × 2 Factorial Randomized Controlled Trial (YouFish Study)

  Oct 11, 2025

• Artificial intelligence for dementia prevention

  Oct 14, 2023

• Association Between Pain and Sarcopenia Among Adults Aged ≥65 Years from Low- and Middle-Income Countries

  Jun 1, 2023

• Epigenetic effects of folate and related B vitamins on brain health throughout life: Scientific substantiation and translation of the evidence for health improvement strategies

  Feb 21, 2023

• Data-driven patient stratification of UK Biobank cohort suggests five endotypes of multimorbidity

  Nov 19, 2022

• Belongingness challenged: Exploring the impact on older adults during the COVID-19 pandemic

  Oct 20, 2022

• Associations between parental bonding, social isolation and loneliness: do associations persist in later life and is isolation a mediator between parental bonding and loneliness?

  Jun 16, 2022

• Insights Into Sibling Relationships and Longevity From Genetics of Healthy Ageing Nonagenarians: The Importance of Optimisation, Resilience and Social Networks

  May 6, 2022

• Association of Self-Reported and Device-Measured Sedentary Behaviour and Physical Activity with Health-Related Quality of Life among European Older Adults

  Dec 16, 2021

• The Mediating Role of Self-Regulation and Self-Efficacy on Physical Activity Change in Community-Dwelling Older Adults (≥65 Years): An Experimental Cross-Lagged Analysis Using Data From SITLESS

  Jun 16, 2021

• The role of senescence in the pathogenesis of atrial fibrillation: A target process for health improvement and drug development

  May 21, 2021

• The Effect of Chair-Based Exercise on Physical Function in Older Adults: A Systematic Review and Meta-Analysis

  Feb 16, 2021

• Association of the use of hearing aids with the conversion from mild cognitive impairment to dementia and progression of dementia: A longitudinal retrospective study

  Feb 14, 2021

Sources: pubmed.ncbi.nlm.nih.gov, openalex.org, api.crossref.org

• Unimolecular GLP-1/Apelin Hybrid Peptides Cause Prominent Appetite Suppression, as Well as Enhancing Insulin Secretion, Beta-Cell Survival and Glycaemic Regulation

  Patents or royalties, Mar 16, 2026

• Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities

  Patents or royalties, Mar 11, 2025

• Recent advances in peptide-based therapies for obesity and type 2 diabetes

  Patents or royalties, Jan 5, 2024

• An update on peptide-based therapies for type 2 diabetes and obesity

  Patents or royalties, Jan 3, 2023

Sources: pubmed.ncbi.nlm.nih.gov

• No significant change in urinary sodium excretion within 48h after Roux-en-Y gastric bypass surgery: the weight LUSER study

  Annals of the Royal College of Surgeons of England, Oct 28, 2026

• Evaluating the cost-effectiveness of enhanced cardiovascular-renal-metabolic (CVRM) screening in UK, France, Germany and Australia: a microsimulation-based enhanced CVRM screening analysis

  Journal of medical economics, Oct 27, 2026

• Orforglipron linked to weight loss in a trial subgroup

  Obesity pillars, Oct 27, 2026

• Artificial Intelligence as a Catalyst for Cell-Based Therapies in Retinal Disease

  Cells, Oct 26, 2026

• Elevated Prostate Specific Antigen is Associated with Prostate Disease, Lower Urinary Tract Symptoms, and Erectile Dysfunction: Findings from 5325 Men

  Research and reports in urology, Oct 19, 2026

• Impact of Sex on Age-Related Changes in Pancreatic Islet Morphology and Beta-Cell Plasticity in Mice

  International journal of molecular sciences, Oct 16, 2026

• Oral Obesity Medicines in the Era of Cardiovascular-Kidney-Metabolic Syndrome (CKM): Beyond Weight Loss Toward Disease Modification

  Drug design, development and therapy, Oct 14, 2026

• Survodutide reduces weight in adults with diabetes and obesity

  The New England journal of medicine, Oct 2, 2026

• Lipoprotein(a) levels and estimated QRISK3 cardiovascular risk in the Randox Health 2025 cohort: a cross-sectional analysis of 14,848 individuals

  Frontiers in cardiovascular medicine, Oct 2, 2026

• Global heart failure cases reached 56 million in 2023

  JAMA cardiology, Oct 1, 2026

• Retatrutide reduces bodyweight in obesity and type 2 diabetes

  Lancet (London, England), Sep 30, 2026

• Eighty Years After Vague: Advances in Understanding Ectopic Fat and Metabolic Dysfunction

  Obesity reviews : an official journal of the International Association for the Study of Obesity, Sep 23, 2026

• Brain age gap linked to memory and gut biology in adults

  EBioMedicine, Sep 9, 2026

• Body composition phenotypes are key predictors of cardiovascular-kidney-metabolic multimorbidity and long-term mortality: insights from a population-based cohort study

  Clinical research in cardiology : official journal of the German Cardiac Society, Sep 3, 2026

• Functional Fitness Deficits in Women with Fibromyalgia Relative to Later-Life Independence Standards: Contributions of Sedentary Time and Physical Activity

  Sports (Basel, Switzerland), Aug 26, 2026

• Impact of diabetes mellitus on the menopausal experience: A scoping review

  Diabetic medicine : a journal of the British Diabetic Association, Aug 22, 2026

• Weight Loss-Dependent Changes in Body Composition and Bone Health in People With Obesity and Type 1 Diabetes Treated With Liraglutide, Semaglutide, or Tirzepatide

  Diabetes/metabolism research and reviews, Aug 5, 2026

• Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023

  JAMA, Jul 29, 2026

• I-SCREEN: Development of an AI-based infrastructure for community-wide screening and prediction of progression in age-related macular degeneration providing accessible shared care

  Eye (London, England), May 14, 2026

• Orthostatic hypotension without co-existent supine hypertension is associated with impaired cerebral oxygenation: findings from the Irish Longitudinal Study on Ageing (TILDA)

  Journal of human hypertension, Apr 26, 2026